| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/06/1997 | WO1997007770A1 Use of mutated subtilisin protease in cosmetic products |
| 03/06/1997 | WO1997007769A2 Chemical compounds |
| 03/06/1997 | WO1997007674A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | WO1997007671A1 Chimeric animal and method for constructing the same |
| 03/06/1997 | WO1997007669A1 Quiescent cell populations for nuclear transfer |
| 03/06/1997 | WO1997007668A1 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 03/06/1997 | WO1997007667A1 Ribozymes targetting hiv and siv |
| 03/06/1997 | WO1997007666A1 Electroporation-mediated molecular transfer in intact plants |
| 03/06/1997 | WO1997007665A1 Production of transgenic plants comprising the winged bean lysine- rich protein |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | WO1997005276A3 Method of sequencing by oligomer hybridisation |
| 03/06/1997 | WO1997005255A3 Helper viruses for preparing recombinant viral vectors |
| 03/06/1997 | WO1997005249A3 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 03/06/1997 | WO1997005248A3 Solution containing chaotropic agent and process using it for isolation of dna, rna and proteins |
| 03/06/1997 | WO1997004106A3 New saccharomyces cerevisiae pectinase sequences and heterologous expression systems derived therefrom |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | WO1996040929A3 Transferrin receptor genes |
| 03/06/1997 | WO1996040768A3 Anti-fungal and anti-bacterial histatin-based peptides |
| 03/06/1997 | WO1994006911A3 Mycoplasma pulmonis antigens and methods and compositions for use in cloning and vaccination |
| 03/06/1997 | DE19531678A1 Prodn. of seedless plants |
| 03/06/1997 | DE19529116A1 DNA encoding Hevea brasiliensis (S)-hydroxy:nitrilase |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2625279A1 Chromatographic purification of adenovirus and aav |
| 03/06/1997 | CA2230929A1 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | CA2230852A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230671A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230637A1 Retinoid x receptors and components of the basal transcription machinery |
| 03/06/1997 | CA2230375A1 Release of intracellular material |
| 03/06/1997 | CA2230239A1 Transgenic animals expressing diabetogenic t-cell receptor transgenes |
| 03/06/1997 | CA2230235A1 Atopy: diagnosis and therapy |
| 03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | CA2230144A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | CA2229789A1 Human jtv1 gene overlaps pms2 gene |
| 03/06/1997 | CA2229749A1 Chimeric antiviral agents which incorporate rev binding nucleic acids |
| 03/06/1997 | CA2229657A1 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 03/06/1997 | CA2229622A1 Mouse integrin subunits |
| 03/06/1997 | CA2229454A1 Circular rna and uses thereof |
| 03/06/1997 | CA2229043A1 Protein/(poly)peptide libraries |
| 03/06/1997 | CA2228820A1 Detection of hepatitis gb virus genotypes |
| 03/06/1997 | CA2227963A1 Novel factors which modify gene transcription and methods of use therefor |
| 03/06/1997 | CA2227950A1 Nucleic acid capture moieties |
| 03/06/1997 | CA2227611A1 Method for identification of mutations using ligation of multiple oligonucleotide probes |
| 03/06/1997 | CA2227040A1 Chemical compounds |
| 03/06/1997 | CA2202907A1 Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors |
| 03/06/1997 | CA2184760A1 Production of tryptophan by the bacterium escherichia coli |
| 03/05/1997 | EP0760100A1 PHAGE/PHAGEMID DISPLAY LIBRARY COMPRISING RANDOMLY CLEAVED cDNA/GENOMIC DNA OR CLONED GENE |
| 03/05/1997 | EP0760014A1 Identification and use of antiviral compounds |
| 03/05/1997 | EP0760013A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 03/05/1997 | EP0760012A1 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage |
| 03/05/1997 | EP0760011A1 Method for testing for mutations in dna from a patient sample |
| 03/05/1997 | EP0760009A1 Processes, apparatus and compositions for characterizing nucleotide sequences |
| 03/05/1997 | EP0760008A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis |
| 03/05/1997 | EP0760007A1 High resolution mapping methods and mapping probes |
| 03/05/1997 | EP0760005A1 DETECTION AND DIFFERENTIATION OF $i(MYCOBACTERIUM TUBERCULOSIS) COMPLEX BACTERIA BY DIRECT VARIANT REPEAT OLIGOTYPING |
| 03/05/1997 | EP0760002A1 Detection of mutation by resolvase cleavage |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759999A1 Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture |
| 03/05/1997 | EP0759998A1 Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture |
| 03/05/1997 | EP0759997A1 Use of tetracycline promoter for the strictly regulated production of recombinant proteins in prokaryotic cells |
| 03/05/1997 | EP0759996A1 Peptide-mediated gene transfer |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759994A1 Thermostable alkaline phosphatase of thermus thermophilus |
| 03/05/1997 | EP0759993A1 DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR $g(a)-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS |
| 03/05/1997 | EP0759992A1 Human papilloma virus inhibition by a hairpin ribozyme |
| 03/05/1997 | EP0759991A1 Genes involved in the biosynthetic pathway of carbapenem |
| 03/05/1997 | EP0759990A1 Ribozymes with product ejection by strand displacement |
| 03/05/1997 | EP0759989A1 IMPROVED $i(BACILLUS THURINGIENSIS) $g(d)-ENDOTOXIN |
| 03/05/1997 | EP0759988A1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 03/05/1997 | EP0759987A1 Human restrictin and nucleic acid sequences |
| 03/05/1997 | EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759982A1 Extraction of heterologous insoluble proteins from bacteria |
| 03/05/1997 | EP0759981A1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759979A1 Antisense inhibition of hepatitis c virus |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759977A1 AN ENZYME WITH $g(b)-(1-6)-ENDOGLUCANASE ACTIVITY |
| 03/05/1997 | EP0759976A1 The isolation and production of catalytic antibodies using phage technology |
| 03/05/1997 | EP0759975A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi |
| 03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759942A1 Interleukin-15 receptors |
| 03/05/1997 | EP0759940A1 A dna molecule encoding a mast cell function-associated antigen (mafa) |
| 03/05/1997 | EP0759938A1 Neurogenic differentiation (neurod) genes and proteins |
| 03/05/1997 | EP0759936A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression |
| 03/05/1997 | EP0759935A1 Recombinant papilloma virus l1 |
| 03/05/1997 | EP0759932A1 Collagen from cell cultures |
| 03/05/1997 | EP0759931A1 An enzymatic process for producing a desired protein from an amino terminal extended protein |
| 03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 03/05/1997 | EP0759927A1 Pteridine nucleotide analogs as fluorescent dna probes |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0759762A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0759694A1 Method for in vivo delivery of therapeutic agents via liposomes |